DNAJC19P7

Across TCGA pan-cancer cohorts, DNAJC19P7 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated DNAJC19P7 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher DNAJC19P7 RNA is associated with better overall survival. In most high-consensus cancer types, elevated DNAJC19P7 expression acts as an unfavorable survival marker, although some lineages such as BLCA and BRCA show a favorable association.

BLCA, KIRC, and ACC are the cancer types where DNAJC19P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.711	0.559	.001	104	view →
KIRC	OS	Tertile	All	0.732	0.833	<.001	90	view →
ACC	OS	Tertile	All	0.181	0.678	<.001	75	view →
BRCA	OS	Tertile	IV	0.820	0.243	.008	60	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	39	view →
LAML	DFS	Tertile	All	0.668	0.258	.001	30	view →
ESCA	OS	Tertile	All	0.572	0.793	.002	26	view →
KIRP	OS	Tertile	III,IV	0.447	0.832	.003	24	view →
COAD	DFS	Tertile	All	0.677	0.797	.021	24	view →
UCS	OS	Tertile	IV	1.000	0.293	.035	18	view →
LIHC	DFS	Tertile	All	0.233	0.471	<.001	18	view →
UCEC	OS	Tertile	All	0.884	0.935	.017	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

DNAJC19P7–BLCA (OS)

Open the BLCA breakdown →